Intermittent Selumetinib for Uveal Melanoma
Clinical trial NCT02768766 · COMPLETED
Trial details
- NCT number
- NCT02768766
- Sponsor
- Shaheer A. Khan
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2020-09-18
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.